A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

Completed · Phase 4

Conditions studied: Diabetes Mellitus, Type 2

In brief

To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus

Key facts

Study ID

NCT00367445

Run by

Pfizer

People needed

30

Starts

2006-09-01

Expected to finish

2007-02-01

Last updated by the study team

2008-01-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diabetes mellitus Type 2

You may not qualify if…

• Severe Asthma, severe COPD
• Smoking

Where it is running

• Pfizer Investigational Site — Chula Vista, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.